Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

35.90p
   
  • Change Today:
    -0.25p
  • 52 Week High: 71.80
  • 52 Week Low: 34.50
  • Currency: UK Pounds
  • Shares Issued: 540.40m
  • Volume: 204,996
  • Market Cap: £194.00m
  • RiskGrade: 119

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
1yr Revenue Growth
28.51% below the market average28.51% below the market average28.51% below the market average28.51% below the market average28.51% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
29.06% above the market average29.06% above the market average29.06% above the market average29.06% above the market average29.06% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
1yr DPS Growth
15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average15.32% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
26.69% below the market average26.69% below the market average26.69% below the market average26.69% below the market average26.69% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average
Price Book Ratio
48.67% above the market average48.67% above the market average48.67% above the market average48.67% above the market average48.67% above the market average
63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average63.27% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
64.51% below the market average64.51% below the market average64.51% below the market average64.51% below the market average64.51% below the market average
22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average22.81% below the sector average
Price Chg 3m
28.43% below the market average28.43% below the market average28.43% below the market average28.43% below the market average28.43% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
10.72% below the market average10.72% below the market average10.72% below the market average10.72% below the market average10.72% below the market average
24.53% above the sector average24.53% above the sector average24.53% above the sector average24.53% above the sector average24.53% above the sector average
Momentum 20
48.06% below the market average48.06% below the market average48.06% below the market average48.06% below the market average48.06% below the market average
39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
6.8% below the market average6.8% below the market average6.8% below the market average6.8% below the market average6.8% below the market average
61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average61.11% above the sector average
ROCE
19.73% above the market average19.73% above the market average19.73% above the market average19.73% above the market average19.73% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
8.76% above the market average8.76% above the market average8.76% above the market average8.76% above the market average8.76% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average
Forecast EPS
64.71% below the market average64.71% below the market average64.71% below the market average64.71% below the market average64.71% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
35.64% above the market average35.64% above the market average35.64% above the market average35.64% above the market average35.64% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Operating Profit Loss
30.14% above the market average30.14% above the market average30.14% above the market average30.14% above the market average30.14% above the market average
74.07% above the sector average74.07% above the sector average74.07% above the sector average74.07% above the sector average74.07% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average41.78% above the market average
57.69% above the sector average57.69% above the sector average57.69% above the sector average57.69% above the sector average57.69% above the sector average
Cash
41.64% above the market average41.64% above the market average41.64% above the market average41.64% above the market average41.64% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
58.9% below the market average58.9% below the market average58.9% below the market average58.9% below the market average58.9% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Buys 1y
Market averageMarket averageMarket averageMarket averageMarket average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
48.88% below the market average48.88% below the market average48.88% below the market average48.88% below the market average48.88% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Brokers Percent Neutral
38.33% above the market average38.33% above the market average38.33% above the market average38.33% above the market average38.33% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 35.90p
Change Today -0.25p
% Change -0.69 %
52 Week High 71.80
52 Week Low 34.50
Volume 204,996
Shares Issued 540.40m
Market Cap £194.00m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
84.29% above the market average84.29% above the market average84.29% above the market average84.29% above the market average84.29% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
65.85% below the market average65.85% below the market average65.85% below the market average65.85% below the market average65.85% below the market average
15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average15.79% above the sector average
Income
7.90% above the market average7.90% above the market average7.90% above the market average7.90% above the market average7.90% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
88.52% below the market average88.52% below the market average88.52% below the market average88.52% below the market average88.52% below the market average
83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average83.78% below the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 3
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 23-Apr-2024

Time Volume / Share Price
11:04 17,800 @ 36.00p
11:02 3,347 @ 36.00p
10:56 120 @ 35.94p
10:52 1,146 @ 35.90p
10:52 902 @ 35.90p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin
Chair Camillo Pane

Top of Page